During the past decade, Mount Sinai School of Medicine Study Coordinator conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 1 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Mount Sinai School of Medicine Study Coordinator" are "Ectopic ACTH Syndrome" (1 trials), "Nelson Syndrome" (1 trials), "Pancreatic Neoplasm" (1 trials), "Pituitary Neoplasm" (1 trials) and "Symptomatic Refractory Resistant Carcinoid Disease" (1 trials). Many other conditions were trialed in "Mount Sinai School of Medicine Study Coordinator" in a lesser frequency.

Most popular intervention types in "Mount Sinai School of Medicine Study Coordinator" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Octreotide" (1 trials), "Pasireotide" (1 trials) and "pasireotide LAR" (1 trials). Other intervention names were less common.

The vast majority of trials in "Mount Sinai School of Medicine Study Coordinator" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Mount Sinai School of Medicine Study Coordinator". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Mount Sinai School of Medicine Study Coordinator, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Mount Sinai School of Medicine Study Coordinator, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".